FDA监管排他性的最新发展

IF 0.2 4区生物学 Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Biotechnology Law Report Pub Date : 2023-06-01 DOI:10.1089/blr.2023.29314.cmh

CHRISTOPHER M. HOLMAN

{"title":"FDA监管排他性的最新发展","authors":"CHRISTOPHER M. HOLMAN","doi":"10.1089/blr.2023.29314.cmh","DOIUrl":null,"url":null,"abstract":"Biotechnology Law ReportVol. 42, No. 3 The Holman ReportRecent Developments in FDA Regulatory ExclusivitiesBy CHRISTOPHER M. HOLMANBy CHRISTOPHER M. HOLMANChristopher M. Holman is a Professor of Law at the University of Missouri-Kansas City School of Law; a Senior Scholar at the Center for the Protection of Intellectual Property at the Antonin Scalia Law School, George Mason University; and the Executive Editor of Biotechnology Law Report.Search for more papers by this authorPublished Online:9 Jun 2023https://doi.org/10.1089/blr.2023.29314.cmhAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 42Issue 3Jun 2023 InformationCopyright 2023, Mary Ann Liebert, Inc., publishersTo cite this article:By CHRISTOPHER M. HOLMAN.Recent Developments in FDA Regulatory Exclusivities.Biotechnology Law Report.Jun 2023.118-131.http://doi.org/10.1089/blr.2023.29314.cmhPublished in Volume: 42 Issue 3: June 9, 2023Online Ahead of Print:May 26, 2023PDF download","PeriodicalId":55354,"journal":{"name":"Biotechnology Law Report","volume":"35 1","pages":"0"},"PeriodicalIF":0.2000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Recent Developments in FDA Regulatory Exclusivities\",\"authors\":\"CHRISTOPHER M. HOLMAN\",\"doi\":\"10.1089/blr.2023.29314.cmh\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Biotechnology Law ReportVol. 42, No. 3 The Holman ReportRecent Developments in FDA Regulatory ExclusivitiesBy CHRISTOPHER M. HOLMANBy CHRISTOPHER M. HOLMANChristopher M. Holman is a Professor of Law at the University of Missouri-Kansas City School of Law; a Senior Scholar at the Center for the Protection of Intellectual Property at the Antonin Scalia Law School, George Mason University; and the Executive Editor of Biotechnology Law Report.Search for more papers by this authorPublished Online:9 Jun 2023https://doi.org/10.1089/blr.2023.29314.cmhAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 42Issue 3Jun 2023 InformationCopyright 2023, Mary Ann Liebert, Inc., publishersTo cite this article:By CHRISTOPHER M. HOLMAN.Recent Developments in FDA Regulatory Exclusivities.Biotechnology Law Report.Jun 2023.118-131.http://doi.org/10.1089/blr.2023.29314.cmhPublished in Volume: 42 Issue 3: June 9, 2023Online Ahead of Print:May 26, 2023PDF download\",\"PeriodicalId\":55354,\"journal\":{\"name\":\"Biotechnology Law Report\",\"volume\":\"35 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2023-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biotechnology Law Report\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1089/blr.2023.29314.cmh\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology Law Report","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/blr.2023.29314.cmh","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

生物技术法律报告卷。作者:CHRISTOPHER M. Holman作者:CHRISTOPHER M. Holman是密苏里大学堪萨斯城法学院的法学教授;乔治梅森大学安东宁·斯卡利亚法学院知识产权保护中心高级学者;也是《生物技术法律报告》的执行主编。搜索本文作者的更多论文出版在线:2023年6月9日https://doi.org/10.1089/blr.2023.29314.cmhAboutSectionsView文章查看全文pdf /EPUB权限& CitationsPermissionsDownload CitationsTrack citations添加到收藏回到出版物ShareShare onFacebookTwitterLinked InRedditEmail查看文章figuresreferencesrelateddetails卷42期3june 2023信息版权2023,Mary Ann Liebert, Inc.，出版商引用本文:by CHRISTOPHER M. HOLMAN。FDA监管排他性的最新发展。生物技术法律报告。20123.6月118-131.http://doi.org/10.1089/blr.2023.29314.cmhPublished卷:42期:2023年6月9日在线提前打印:2023年5月26日pdf下载

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Recent Developments in FDA Regulatory Exclusivities

Biotechnology Law ReportVol. 42, No. 3 The Holman ReportRecent Developments in FDA Regulatory ExclusivitiesBy CHRISTOPHER M. HOLMANBy CHRISTOPHER M. HOLMANChristopher M. Holman is a Professor of Law at the University of Missouri-Kansas City School of Law; a Senior Scholar at the Center for the Protection of Intellectual Property at the Antonin Scalia Law School, George Mason University; and the Executive Editor of Biotechnology Law Report.Search for more papers by this authorPublished Online:9 Jun 2023https://doi.org/10.1089/blr.2023.29314.cmhAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 42Issue 3Jun 2023 InformationCopyright 2023, Mary Ann Liebert, Inc., publishersTo cite this article:By CHRISTOPHER M. HOLMAN.Recent Developments in FDA Regulatory Exclusivities.Biotechnology Law Report.Jun 2023.118-131.http://doi.org/10.1089/blr.2023.29314.cmhPublished in Volume: 42 Issue 3: June 9, 2023Online Ahead of Print:May 26, 2023PDF download

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Biotechnology Law Report 工程技术-生物工程与应用微生物

CiteScore

0.30

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： The leading authoritative journal since 1982 devoted to the evolving body of law and government regulation concerning biotechnology, particularly in the industries in which new products from these technologies are developing the most rapidly: pharmaceuticals, chemicals, agriculture, food processing, energy, mineral recovery, and waste treatment. All legal aspects are rapidly reported, and critical and often hard-to-obtain documents are reproduced.